Stock AnalysisMay 18, 2026 · 5 min read

Is Merck Stock (MRK) Halal? A Complete Analysis

Merck & Co. (MRK) is a US-headquartered global pharmaceutical company best known for the Keytruda oncology franchise, the Gardasil HPV vaccine, and a broad portfolio of prescription medicines and animal-health products — but is it permissible for Muslim investors? Here's a full Sharia screening breakdown.

The Short Answer

Merck stock (MRK) is generally considered halal by most Islamic scholars and Sharia screening criteria. Merck & Co. (known as MSD outside the United States and Canada) is a US-headquartered global pharmaceutical company best known for the Keytruda oncology franchise, the Gardasil HPV vaccine, and a broad portfolio of prescription medicines and animal-health products.

Pharmaceutical and vaccine development, manufacture, and distribution is unambiguously permissible at the activity level under standard Sharia methodology — Merck's medicines serve to preserve life and treat serious disease, a clearly permissible therapeutic mission. The financial screen passes comfortably with conservative leverage.

Sharia Screening Methodology

Islamic scholars use several criteria to screen stocks:

  • Business activity screen: Is the company's primary business halal?
  • Debt ratio: Total debt / market cap must be under 33%
  • Interest income: Interest income / total revenue must be under 5%
  • Haram revenue: Revenue from haram sources must be under 5%
  • Receivables ratio: Total receivables / total assets must be under 49–70% (varies by board)

Merck's Business Activity

Merck is organized into two reporting segments:

  • Pharmaceutical: Prescription human-health medicines and vaccines, including:
    • Oncology: Keytruda (pembrolizumab) — an anti-PD-1 immune checkpoint inhibitor that is the largest-selling oncology drug globally, used across numerous tumor types; plus other oncology medicines
    • Vaccines: Gardasil and Gardasil 9 for HPV, Pneumovax and Vaxneuvance for pneumococcal disease, ProQuad/M-M-R II for measles-mumps-rubella, RotaTeq for rotavirus, and the Ervebo Ebola vaccine
    • Cardiovascular and Diabetes: Januvia and Janumet (sitagliptin) for type-2 diabetes, plus other cardiometabolic medicines
    • HIV: Isentress and the Delstrigo and Pifeltro single-tablet regimens
    • Hospital and Specialty Care: Bridion (sugammadex) and other hospital-administered medicines
    • Other primary-care medicines
  • Animal Health: Livestock and companion-animal pharmaceuticals, vaccines, parasiticides, and animal-identification products through Merck Animal Health — one of the global leaders in the animal-health category

All segments are unambiguously permissible at the activity level under standard Sharia methodology.

Concerns to Be Aware Of

1. Porcine-Derived Materials in Some Vaccines

Some vaccines and pharmaceutical products may contain trace porcine-derived or other animal-derived materials in manufacturing or formulation. Scholars generally classify medicines as permissible under necessity (darura) even where alternative formulations are unavailable — the prohibition on porcine materials in food does not extend to life-saving medicines where no halal alternative exists. This is a consumer-product consideration rather than a corporate-Sharia screening concern.

2. Animal-Health Reproductive-Management Products

Merck Animal Health includes some reproductive-management product categories where individual investors may wish to apply additional scrutiny. These are a small share of total revenue and the broader animal-health business — vaccines, parasiticides, anti-infectives — is unambiguously permissible.

3. Minor Interest Income

Merck holds substantial cash and short-term investment balances that generate small interest income. This is well below the 5% Sharia threshold but warrants purification of a small portion of dividends.

4. Keytruda Patent-Cliff Considerations

Keytruda faces loss of exclusivity beginning around 2028. This is a business-quality and revenue-concentration consideration rather than a Sharia screen concern. Merck has been investing heavily in pipeline diversification to offset future Keytruda revenue erosion.

Financial Ratios (2025)

Based on Merck's most recent financial statements:

  • Total Debt / Market Cap: Well under 33% ✅
  • Interest Income / Revenue: Well under 5% ✅
  • Haram Revenue: Negligible ✅
  • Business Activity: Permissible pharmaceutical and animal-health ✅

Verdict from Major Screening Agencies

Merck stock is generally screened as compliant (halal) with purification by:

  • Zoya App — Compliant with purification ✅
  • MSCI Islamic criteria — Generally included ✅
  • Most major Sharia advisory boards — Compliant with purification of small interest-income component ✅

Bottom Line

Merck & Co. (MRK) is generally halal with purification for Muslim investors. The core business — pharmaceutical and vaccine development, manufacture, and distribution, plus animal-health products — is unambiguously permissible at the activity level under standard Sharia methodology. Apply purification of any small interest-income component in the income statement.

For Muslim investors seeking US large-cap pharmaceutical exposure, MRK offers concentrated oncology exposure through Keytruda alongside a broad vaccine, primary-care, and animal-health portfolio, comparable in profile to other halal-screened pharma names like Eli Lilly (LLY), AbbVie (ABBV), and Bristol-Myers Squibb (BMY).

🔍 Check Other Stocks

Want to check if another stock is halal? Use our free screener.

Open Halal Checker →
💰
Already know you want to invest halal?
Get 50% off Islamicly — comprehensive halal screening + digital gold + portfolios.
Use code:ZAKAT50→ 50% OFF
Use Code ZAKAT50 →
📬

Get Weekly Halal Investing Insights

No spam. Unsubscribe anytime.